Keyphrases
Menopause
100%
Cyclophosphamide
100%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
100%
Primary Ovarian Insufficiency
100%
Antibody-associated
27%
Associated Vasculitis
27%
Odds Ratio
18%
Postmenopausal Women
18%
Confidence Interval
18%
Early Menopause
18%
Menopause Onset
18%
Involuntary childlessness
18%
Early Primary
18%
Drug Use
9%
Cumulative Dose
9%
Orally Administered
9%
Childbearing Women
9%
Immunosuppressive Medication
9%
Oral Cyclophosphamide
9%
Gonadal Function
9%
Medicine and Dentistry
ANCA Associated Vasculitis
100%
Cyclophosphamide
100%
Primary Ovarian Insufficiency
100%
Vasculitis
25%
Early Menopause
16%
Premenopause
16%
Odds Ratio
16%
Side Effect
8%
Drug Therapy
8%
Immunosuppressive Drug
8%
Gonad Function
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
ANCA Associated Vasculitis
100%
Premature Ovarian Failure
100%
Vasculitis
25%
Early Menopause
16%
Side Effect
8%
Immunosuppressive Agent
8%